World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Travel

Lockheed Martin Introduces PAC-3 ACE™ – A High-Performance, Low-Cost Interceptor

Cision PR Newswire by Cision PR Newswire
July 20, 2026
in Press Releases - Travel
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

PAC-3 ACE costs less than half of PAC-3 MSE

FARNBOROUGH, England, July 20, 2026 /PRNewswire/ — Lockheed Martin (NYSE: LMT) today announced the introduction of the PAC-3® Adapted Capability Effector (PAC-3 ACE™), a low-cost interceptor built to defeat a wide range of air and missile threats for less than half the cost of a PAC-3 MSE per unit.

A rendering of Lockheed Martin’s PAC-3 ACE interceptor.

PAC-3 ACE will give allied forces a rapidly fielded, complementary air defense effector option that can be deployed in record time. To achieve this, Lockheed Martin will collaborate with American and European industry partners and suppliers, enhancing the resilience of the U.S. defense industrial base worldwide.

THE BIG PICTURE
Built on the proven PAC‑3 fire‑control system and fully linked to the Patriot weapon system and the Integrated Battle Command System (IBCS), PAC‑3 ACE speeds up development, testing and deployment far beyond traditional programs. It also ensures allied forces can field a common interceptor and bolster the PAC‑3 network at the same time.

WHY IT MATTERS

  • Cost-effective performance: Significantly lowers the cost-per-kill against a wide range of threats, with the reliability PAC-3 is known for, while providing magazine depth the current global climate necessitates.
  • Rapid fielding: Uses highly effective and battle-proven PAC-3 software and IBCS integration to shorten development cycles and achieve rapid initial production.
  • Multi-threat coverage: Designed to counter airbreathing threats, cruise missiles, close-range and short-range ballistic missiles within a single platform.
  • Allied resilience: Joint development and production with European partners creates a shared, interoperable interceptor that strengthens transatlantic defense posture.

EXPERT PERSPECTIVE
“American and allied warfighters need a solution that is battle-tested and budget-smart, and PAC-3 ACE delivers exactly that by building on the unrivaled performance of the PAC-3 MSE,” said Tim Cahill, president, Lockheed Martin Missiles and Fire Control. “As we look to partner with our allies, we can further enhance resiliency and ensure our forces can swiftly counter emerging threats today and tomorrow.”

About Lockheed Martin
Lockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Our all-domain mission solutions and 21st Century Security® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of ready. More information at Lockheedmartin.com.

Lockheed Martin Logo.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lockheed-martin-introduces-pac-3-ace–a-high-performance-low-cost-interceptor-302829199.html

SOURCE Lockheed Martin

Cision PR Newswire

Cision PR Newswire

Related Posts

Xenia Hotels & Resorts Announces Timing of Third Quarter 2026 Earnings Release and Conference Call

September 10, 2026

Cook County Treasurer to Host Central American Independence Day Reception Following Daley Plaza Flag Raising Ceremony

September 10, 2026

Avianca Elevates the Travel Experience for U.S. Customers With Expanded Premium Offerings and New Onboard Benefits

September 10, 2026

Pacaso Brings Co-Ownership to the Banks of the Seine With the Launch of Riverfront Pied-à-terre in Paris’ 6th Arrondissement

September 9, 2026

CAP JULUCA, A BELMOND HOTEL, ANGUILLA: A NEW SEASON INSPIRED BY MAUNDAYS BAY, THE BEST BEACH IN THE WORLD

September 9, 2026

Capstone Partners Reports: Aerospace & Defense M&A Activity Shines in Muted Market

September 9, 2026

Popular News

  • The Parisian Macao Celebrates 10th Anniversary

    0 shares
    Share 0 Tweet 0
  • From Bangkok to the World: Central Park Unveils “Bangkok’s World Stage” as Its Next Global Ambition

    0 shares
    Share 0 Tweet 0
  • Gregorys Coffee Goes Bananas for Fall with New Seasonal Sips and Bigger, Better Breakfast Lineup

    0 shares
    Share 0 Tweet 0
  • Faruqi & Faruqi, LLP Urges Wise Group plc (NASDAQ: WSE) Investors to Seek Counsel Before the September 29, 2026 Lead Plaintiff Deadline in the Securities Class Action

    0 shares
    Share 0 Tweet 0
  • TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler